It is also, generally, treatable and manageable. Medications and protocols exist that help those with MS function, contribute, and enjoy life.

That medication, however, doesn’t come cheap. Annual costs range from $5,000 to over $20,000. Most health plans cover at least part of this expense, and “big pharma” has programs to help ease that burden, as well.

At least, that’s the case in the good ole U S of A.

Across the pond, however, the outlook for those with MS just got bleaker:

That’s from the Telegraph, another British paper. It seems that the much-vaunted National Health service (NHS) is facing a major funding crisis:

“(S)enior figures in strategic health authorities (SHAs) and the deaneries have been warned at meetings with DoH officials that their budgets for 2006-07 are likely to be cut. A letter seen by The Daily Telegraph from an SHA to the directors of finance of 10 primary care trusts and seven NHS trusts warns them to plan on the basis that their budgets will be cut by 10 per cent.” (ibid)

It is also, generally, treatable and manageable. Medications and protocols exist that help those with MS function, contribute, and enjoy life.

That medication, however, doesn’t come cheap. Annual costs range from $5,000 to over $20,000. Most health plans cover at least part of this expense, and “big pharma” has programs to help ease that burden, as well.

At least, that’s the case in the good ole U S of A.

Across the pond, however, the outlook for those with MS just got bleaker:

That’s from the Telegraph, another British paper. It seems that the much-vaunted National Health service (NHS) is facing a major funding crisis:

“(S)enior figures in strategic health authorities (SHAs) and the deaneries have been warned at meetings with DoH officials that their budgets for 2006-07 are likely to be cut. A letter seen by The Daily Telegraph from an SHA to the directors of finance of 10 primary care trusts and seven NHS trusts warns them to plan on the basis that their budgets will be cut by 10 per cent.” (ibid)